Your one point of contact for Actelion services and support
About PAH

PAH Overview

Map

PAH Pathways Interactive Resource Locator

PAH Pathways offers a wealth of resources including one-on-one support from PAH Pathways counselors in your area.
Learn more ยป

What is pulmonary arterial hypertension?

Pulmonary arterial hypertension (PAH) is a disorder that affects the pulmonary artery—the large blood vessel that carries blood from the heart to the lungs—and the hundreds of tiny blood vessels that branch off from it.

PAH starts when the small vessels that supply blood to the lungs constrict, or tighten up. This makes it more difficult for blood to get through to the lungs, and as a result the heart must pump harder. Over time, scarring (fibrosis) of the blood vessels makes them stiffer and thicker, and some may become completely blocked. The extra stress causes the heart to enlarge and become less flexible. As this cycle continues, less and less blood is able to flow out of the heart, through the lungs, and into the body, and more and more symptoms can begin to appear.

Healthy blood vessels have a balance of naturally occurring chemicals. In PAH, the balance is disturbed. There is too much of some chemicals and too little of others.1 One of these naturally occurring chemicals is called prostacyclin, which helps widen or dilate blood vessels.2 In patients with PAH, there is not enough prostacyclin found in the blood vessels.

Another naturally occurring substance is called endothelin, which plays a role in regulating blood flow. With PAH, too much endothelin is produced in the body. This extra endothelin may cause blood vessels to tighten.

PAH Overview

Statements are based on observations reported from in vitro or animal trials. The clinical significance in humans is unknown.

PAH Overview

Feeling breathless

In PAH, the resistance in the blood vessels makes it harder for your heart to pump blood into your lungs. Less blood gets to the lungs to pick up the oxygen your body needs. This causes less oxygen to get into the cells of your body, making you feel short of breath.3

Causes of PAH

There are four general causes for pulmonary arterial hypertension (PAH):

  • Inherited: PAH can be passed down to you genetically from your parents
  • Certain medications or drugs: Taking the phen-fen diet drug combination, cocaine, or methamphetamines, for example, can lead to PAH4
  • Underlying disease: Also known as secondary PAH; underlying diseases can create the conditions that lead to PAH. Secondary PAH may be associated with certain medical conditions including:
    • Collagen vascular disease, also known as "connective tissue disease." This includes diseases such as scleroderma, lupus (systemic lupus erythematosus), rheumatoid arthritis, and others
    • Congenital heart disease
    • HIV infection
    • Sickle cell disease
  • No known cause: Also known as "idiopathic," this common type of PAH means that scientists haven't yet uncovered the entire process that leads to PAH.

The good news is that research is ongoing and scientists and physicians know much more about how PAH develops and how to control it today than they did ten years ago. Although a cure has not yet been found, much progress has been made in terms of understanding the disease and multiple treatments are now available.4

References: 1. McLaughlin V, McGoon MD. Pulmonary arterial hypertension. Circulation. 2006;114:1417-1431. 2. National Heart Lung and Blood Institute. Available at http://www.nhlbi.nih.gov/health/dci/Diseases/pah/pah_what.html. Accessed October 10, 2007. 3. Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet. 1998;352:719-725. 4. Gibbs J. Making a Diagnosis in PAH. Eur Respir Rev. 2007;16:102,8-12.

Tracleer is indicated for patients with pulmonary arterial hypertension (PAH) WHO Class II-IV.

Tracleer Important Safety Information

Because of the risks associated with Tracleer, this medication may be prescribed only by your doctor through the Tracleer Access Program. Liver damage: Tracleer can cause serious liver damage, including in rare cases liver failure and, in situations with regular liver testing, unexplained liver cirrhosis. So you must have a blood test to check your liver function before you start Tracleer and each month after that. Call your doctor right away if you have any of these symptoms of liver problems: nausea, vomiting, fever, unusual tiredness, abdominal (stomach area) pain, or yellowing of the skin or whites of your eyes (jaundice). Serious birth defects: Tracleer is very likely to cause serious birth defects. It is important not to be or to become pregnant while taking Tracleer and to have a pregnancy test before you start the drug and each month thereafter. It is very important for you to use reliable forms of birth control while taking Tracleer. Hormonal contraceptives should not be used alone because they may not be effective in patients taking Tracleer.

Do not take Tracleer with glyburide or cyclosporine-A, because they may increase your chance for side effects.

Please see full Prescribing Information, including BOXED WARNING and Medication Guide.

Ventavis is indicated for the treatment of pulmonary arterial hypertension (WHO Group I) in patients with NYHA Class III or IV symptoms.

Important safety information about Ventavis

Because it lowers your blood pressure, Ventavis may cause dizziness, lightheadedness, and fainting. With Ventavis, the most common side effects are reddening of the face caused by dilation of blood vessels (flushing), increased cough, low blood pressure (hypotension), headaches, nausea, spasm of the jaw muscles that causes trouble opening your mouth, and fainting (syncope); other serious adverse events reported with the use of Ventavis include congestive heart failure, chest pain, supraventricular tachycardia, dyspnea, peripheral edema, and kidney failure. Before you start taking Ventavis, talk to your doctor to make sure you understand the side effects you might get.

Please see accompanying full Prescribing Information.